BMS fined, former execs charged

Bristol-Myers Squibb agreed to pay a $300 million fine to defer prosecution on charges it manipulated sales and income figures, even as two former senior executives were charged with crimes related to the scandal. That brings its total fines to $800 million. The New York Times reported that the deal was in the works last week. Former CFO Frederick Schiff and executive vice president Richard Lane were charged with conspiracy and securities fraud.

- read this story from the AP for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.